Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The hemostatic and inflammatory systems may activate each other. Endometriosis is a chronic
inflammatory disease affecting 10% of women. The objective of this study is to compare the
hemostatic effects of two treatments widely prescribed to women with endometriosis: the
levonorgestrel intrauterine system (LNG-IUS) and the gonadotropin-releasing hormone analog
(GnRHa) leuprolide acetate.
Hypothesis:
H0: There is no alteration in hemostatic system with the use of GnRHa or LNG-IUS H1: There is
alteration in hemostatic system with the use of GnRHa or LNG-IUS
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico Fundação de Amparo à Pesquisa do Estado de São Paulo